Biogen, Elan Halt Drug After Patient Dies

NEW YORK (Reuters) - Biogen Idec on Monday suspended sales of their much-heralded new multiple sclerosis drug Tysabri after a patient died from a rare and often fatal infection of the central nervous system.

Continue to Biogen, Elan Halt Drug After Patient Dies on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz